Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BY 4.0PeerJ

Machine learning–derived intracellular protein–based prognostic model reflecting a senescence-associated secretory phenotype-driven immunosuppressive microenvironment in lung adenocarcinoma

6 affiliations
  1. 1Department of Oncology, Xi’an Chang’an District Hospital, Xi’an, Shaanxi, China
  2. 2Department of Pathology, Xi’an Chang’an District Hospital, Xi’an, Shaanxi, China
  3. 3Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China
  4. 4Department of Nuclear Medicine, Xi’an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi’an, Shaanxi, China
  5. 5Department of Oncology, Xi’an People’s Hospital (Xi’an Fourth Hospital), Xi’an, Shaanxi, China
  6. 6Department of Respiratory Medical Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China

Abstract

Background: This study aimed to investigate the associations of senescence-associated secretory phenotype (SASP)-related genes with the tumor immune microenvironment (TIME) and clinical outcomes in lung adenocarcinoma (LUAD) and to develop and evaluate a prognostic signature for risk stratification and exploratory treatment-response prediction.

Methods: Non-negative matrix factorization (NMF) was conducted to identify distinct molecular subtypes. Least absolute shrinkage and selection operator (LASSO), Random Forest, and extreme gradient boosting (XGBoost) were utilized to identify core prognostic SASP genes. The expression patterns of selected SASP-related genes were explored using multi-omics datasets, LUAD cell lines, and clinical specimens.

Results: Cluster 1 was associated with significantly shorter overall survival (OS), enhanced senescence pathway activity, and computationally inferred immunosuppressive and immune-exclusion features. Five intracellular SASP regulators— ANGPTL4 , CDKN2A , H2AX , MMP1 , and CCL20 —were selected through machine learning to construct the SASP Protein Regulator Score (SASP-PRS). A high SASP-PRS was associated with the activation of senescence/SASP and cell-cycle pathways, suppression of antitumor immune signatures, and distinct immune-checkpoint and chemokine expression profiles. A higher SASP-PRS was also associated with advanced disease stage, poorer OS, predicted lower responsiveness to immunotherapy, lower predicted sensitivity to erlotinib, and higher predicted sensitivity to selected chemotherapeutic agents. The nomogram incorporating the SASP-PRS demonstrated discriminatory ability and calibration for predicting 1-, 3-, and 5-year OS in the analyzed LUAD cohorts.

Conclusion: These findings suggest that SASP-related gene-expression patterns are associated with LUAD molecular subtypes, senescence signaling, computationally inferred immune features, and treatment-related outcomes. The SASP-PRS may serve as a potential biomarker for prognostic stratification in LUAD. However, its utility for treatment-response assessment remains exploratory. Prospective external validation and functional studies are required to establish its clinical applicability and clarify the mechanisms linking SASP-related networks to the LUAD immune microenvironment.

Related

  1. 644 Combining radiopharmaceutical ligand therapy with CAR T cells to overcome the heterogeneous immunosuppressive prostate tumor microenvironment
    Shuai Yang, Tanya Dorff, Jiangyue Liu +22
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textMedical imaging & radiologyDOAJ
  2. CNS localization drives a profoundly immunosuppressive microenvironment in B‑cell lymphoma
    Jenni Niemi, Oscar Badillo-Godinez, Mats Hellström
    Scientific ReportsPeer-reviewedCC BY 4.0Full textNeurologyCrossref
  3. Bone Metastasis and the Immunosuppressive Tumor Microenvironment: Mechanisms and Therapeutic Strategies
    Minghao Ba, Yuzhu Chen, Peng Jiang +3
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Zika virus oncolytic signaling reverts immunosuppressive and angiogenic glioblastoma microenvironment in vitro and in vivo
    G. Pinheiro Alves de Freitas, J. H. Quintanilla, J. M. Janeiro +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. NOTCH3/JAG1 signaling is associated with immunosuppressive tumor microenvironment features in ovarian cancer: links to nutritional risk, CD163+ macrophages, and CD8+ T cell exclusion
    Hui Zhu, Ying He, Rui Hao +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthFrontiersCrossref
BibTeX
@article{chang2026machine,
  title = {{Machine learning–derived intracellular protein–based prognostic model reflecting a senescence-associated secretory phenotype-driven immunosuppressive microenvironment in lung adenocarcinoma}},
  author = {Xiaoning Chang and Lihong Jiang and Lingxiao Zhang and Tong Ren and Chaoxin Fan and Pei Li},
  journal = {PeerJ},
  year = {2026},
  month = oct,
  doi = {10.7717/peerj.21835},
  url = {https://peerj.com/articles/21835},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Machine learning–derived intracellular protein–based prognostic model reflecting a senescence-associated secretory phenotype-driven immunosuppressive microenvironment in lung adenocarcinoma
AU  - Xiaoning Chang
AU  - Lihong Jiang
AU  - Lingxiao Zhang
AU  - Tong Ren
AU  - Chaoxin Fan
AU  - Pei Li
PY  - 2026
DA  - 2026/10/21
JO  - PeerJ
DO  - 10.7717/peerj.21835
UR  - https://peerj.com/articles/21835
AB  - Background: This study aimed to investigate the associations of senescence-associated secretory phenotype (SASP)-related genes with the tumor immune microenvironment (TIME) and clinical outcomes in lung adenocarcinoma (LUAD) and to develop and evaluate a prognostic signature for risk stratification and exploratory treatment-response prediction.  Methods: Non-negative matrix factorization (NMF) was conducted to identify distinct molecular subtypes. Least absolute shrinkage and selection operator (LASSO), Random Forest, and extreme gradient boosting (XGBoost) were utilized to identify core prognostic SASP genes. The expression patterns of selected SASP-related genes were explored using multi-omics datasets, LUAD cell lines, and clinical specimens.  Results: Cluster 1 was associated with significantly shorter overall survival (OS), enhanced senescence pathway activity, and computationally inferred immunosuppressive and immune-exclusion features. Five intracellular SASP regulators— ANGPTL4 , CDKN2A , H2AX , MMP1 , and CCL20 —were selected through machine learning to construct the SASP Protein Regulator Score (SASP-PRS). A high SASP-PRS was associated with the activation of senescence/SASP and cell-cycle pathways, suppression of antitumor immune signatures, and distinct immune-checkpoint and chemokine expression profiles. A higher SASP-PRS was also associated with advanced disease stage, poorer OS, predicted lower responsiveness to immunotherapy, lower predicted sensitivity to erlotinib, and higher predicted sensitivity to selected chemotherapeutic agents. The nomogram incorporating the SASP-PRS demonstrated discriminatory ability and calibration for predicting 1-, 3-, and 5-year OS in the analyzed LUAD cohorts.  Conclusion: These findings suggest that SASP-related gene-expression patterns are associated with LUAD molecular subtypes, senescence signaling, computationally inferred immune features, and treatment-related outcomes. The SASP-PRS may serve as a potential biomarker for prognostic stratification in LUAD. However, its utility for treatment-response assessment remains exploratory. Prospective external validation and functional studies are required to establish its clinical applicability and clarify the mechanisms linking SASP-related networks to the LUAD immune microenvironment.
SN  - 2167-8359
ER  -